Identifying a typology of men who use anabolic androgenic steroids (AAS)

被引:65
|
作者
Zahnow, Renee [1 ]
McVeigh, Jim [2 ]
Bates, Geoff [2 ]
Hope, Vivian [2 ]
Kean, Joseph [2 ]
Campbell, John [3 ]
Smith, Josie [4 ]
机构
[1] Univ Queensland, Sch Social Sci, St Lucia, Qld 4072, Australia
[2] Liverpool John Moores Univ, Publ Hlth Inst, Henry Cotton Campus,15-21 Webster St, Liverpool L3 2ET, Merseyside, England
[3] Scottish Natl Blood Transfus Serv, Res Dev & Innovat, Edinburgh, Midlothian, Scotland
[4] Publ Hlth Wales, Hlth Promot, Cardiff, S Glam, Wales
关键词
Anabolic steroids; Image and performance enhancing drugs; Bodybuilding; Harm minimisation; Risk; CLUSTER-ANALYSIS; DRUG-USE;
D O I
10.1016/j.drugpo.2018.02.022
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Despite recognition that the Anabolic Androgenic Steroid (AAS) using population is diverse, empirical studies to develop theories to conceptualise this variance in use have been limited. Methods: In this study, using duster analysis and multinomial logistic regression, we identify typologies of people who use AAS and examine variations in motivations for AAS use across types in a sample of 611 men who use AAS. Results: The cluster analysis identified four groups in the data with different risk profiles. These groups largely reflect the ideal types of people who use AAS proposed by Christiansen et al. (2016): Cluster 1 (You Only Live Once (YOLO) type, n = 68, 11.1%) were younger and motivated by fat loss; Cluster 2 (Well-being type, n = 236, 38.6%) were concerned with getting fit; Cluster 3 (Athlete type, n = 155, 25.4%) were motivated by muscle and strength gains; Cluster 4 (Expert type, n = 152, 24.9%) were focused on specific goals (i.e. not 'getting fit'). Conclusion: The results of this study demonstrate the need to make information about AAS accessible to the general population and to inform health service providers about variations in motivations and associated risk behaviours. Attention should also be given to ensuring existing harm minimisation services are equipped to disseminate information about safe intra-muscular injecting and ensuring needle disposal sites are accessible to the different types.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 50 条
  • [1] Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men
    Bonnecaze, Alex K.
    O'Connor, Thomas
    Aloi, Joseph A.
    AMERICAN JOURNAL OF MENS HEALTH, 2020, 14 (06)
  • [2] Outline of a typology of men's use of anabolic androgenic steroids in fitness and strength training environments
    Christiansen, Ask Vest
    Vinther, Anders Schmidt
    Liokaftos, Dimitris
    DRUGS-EDUCATION PREVENTION AND POLICY, 2017, 24 (03) : 295 - 305
  • [3] IMMUNE MODULATION ASSOCIATED WITH ANDROGENIC ANABOLIC STEROIDS (AAS)
    HERTELENDY, ZI
    MENDENHALL, CL
    GHOSN, SJ
    ROUSTER, SD
    SCOTT, RL
    GROSSMAN, CJ
    ROSELLE, GA
    HEPATOLOGY, 1988, 8 (05) : 1446 - 1446
  • [4] Effects of androgenic anabolic steroids (AAS) on apolipoproteins and lipoprotein(a)
    Wolffenbuttel, BHR
    Hartgens, F
    Rietjens, G
    Keizer, HA
    Kuipers, H
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 171 - 171
  • [5] Polysubstance use practices among women using anabolic-androgenic steroids (AAS)
    Piatkowski, Timothy
    Robertson, Jonathan
    Dunn, Matthew
    PERFORMANCE ENHANCEMENT & HEALTH, 2023, 11 (02)
  • [6] Treatments for people who use anabolic androgenic steroids: a scoping review
    Bates, Geoff
    Van Hout, Marie-Claire
    Teck, Joseph Tay Wee
    McVeigh, Jim
    HARM REDUCTION JOURNAL, 2019, 16 (01)
  • [7] Treatments for people who use anabolic androgenic steroids: a scoping review
    Geoff Bates
    Marie-Claire Van Hout
    Joseph Tay Wee Teck
    Jim McVeigh
    Harm Reduction Journal, 16
  • [8] THE PREVALENCE OF PRIOR USE OF ANABOLIC ANDROGENIC STEROIDS IN YOUNG HYPOGONADAL MEN
    Rajanahally, Saneal
    Coward, Robert
    Smith, Ryan
    Kovac, Jason
    Lipshultz, Larry
    JOURNAL OF UROLOGY, 2013, 189 (04): : E571 - E571
  • [9] Consequences of use of anabolic androgenic steroids
    Casavant, Marcel J.
    Blake, Kathleen
    Griffith, Jill
    Yates, Andrew
    Copley, Larae M.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2007, 54 (04) : 677 - +
  • [10] USE OF ANABOLIC ANDROGENIC STEROIDS BY ATHLETES
    GOLDBERG, L
    BOSWORTH, E
    ELLIOT, DL
    BENTS, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (11): : 775 - 776